サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1426372

多汗症治療の世界市場レポート 2024

Hyperhidrosis Treatment Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
多汗症治療の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

多汗症治療の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には5.9%の年間複合成長率（CAGR）で19億9,000万米ドルに成長すると予想されます。 多汗症治療の予測期間で予想される増加には、いくつかの要因が考えられます。これらには、患者中心の治療アプローチへの移行、世界の健康意識の高まり、局所治療の進歩、外科手術の革新、包括的な皮膚科診療への多汗症治療の統合が含まれます。予測期間中に予想される主な動向には、個々の患者のニーズに合わせた個別化治療アプローチの採用、多汗症治療に使用される医療機器の技術革新、過剰発汗をターゲットとした経口薬の継続的な研究開発、診察や経過観察のための遠隔医療の利用、医療業界における連携やパートナーシップの強化などがあります。

予想される糖尿病の発生率の増加により、多汗症治療市場の拡大が促進される見込みです。高血糖値を引き起こす異常なインスリンレベルを特徴とする糖尿病は、汗腺を制御する神経系に影響を及ぼし、過剰な発汗や多汗症を引き起こす可能性があります。この病状が発汗調節と体温維持に及ぼす影響は、多汗症の一因となる可能性があります。たとえば、2021年12月の国際糖尿病連盟のデータは、2021年には20歳から79歳までの成人5億3,700万人が糖尿病に罹患していることを浮き彫りにし、2030年までに6億4,300万人、2045年までに推定7億8,300万人に増加すると予測しています。糖尿病の有病率は、多汗症治療市場の重要な推進力です。

ヘルスケア支出の増加傾向は、多汗症治療市場の成長を促進すると予想されます。ヘルスケア支出には、治療、設備、投薬、予防ケアなどのさまざまな医療サービスへの支出が含まれます。ヘルスケア費の急増により、多汗症とそれが個人の日常生活や生活の質に及ぼす影響についての意識が高まっています。この意識の高まりにより、新しい治療法、外科的介入、および関連する健康状態への配慮が開発されました。たとえば、英国国家統計局の報告書によると、2020年から2021年にかけてヘルスケア支出が名目で9.4%、実質で9.7%増加しました。具体的には、予防医療支出は2021年に457億2,000万米ドルに急増し、前年の2倍となった。その結果、ヘルスケア費の高騰により、多汗症治療市場の成長が促進されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の多汗症治療市場、治療タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 局所治療
  • 外科的治療
  • ボツリン毒素A
  • イオン導入
  • レーザー治療
  • その他の治療法
  • 世界の多汗症治療市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 経口
  • 注射
  • 世界の多汗症治療市場、疾患別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 腋窩多汗症
  • 手掌多汗症
  • 足底多汗症
  • その他の病気
  • 世界の多汗症治療市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 外来手術センター
  • 小売薬局
  • オンライン

第7章 地域および国の分析

  • 世界の多汗症治療市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界の多汗症治療市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 多汗症治療市場の競合情勢
  • 多汗症治療市場の企業プロファイル
    • Pfizer Inc.
    • AbbVie Inc.
    • Sanofi SA
    • AstraZeneca Plc
    • GSK plc

第31章 その他の大手および革新的な企業

  • Teva Pharmaceutical Industries Ltd.
  • Mylan NV
  • Cynosure LLC
  • Ipsen SA
  • Galderma SA
  • Merz Pharma GmbH &Co. KGaA
  • Daewoong Pharmaceutical Co. Ltd.
  • Supernus Pharmaceuticals Inc
  • Kaken Pharmaceutical Co Ltd
  • Avanor Healthcare Ltd.
  • HUGEL Inc.
  • Evolus Inc.
  • Revance Therapeutics Inc.
  • Dermira Inc.
  • Sesderma SL

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13384

Hyperhidrosis is a medical condition characterized by excessive sweating beyond what is necessary for regulating the body's temperature. It can affect various areas of the body, such as the underarms, palms, and soles of the feet. Hyperhidrosis treatment involves medical interventions and therapies designed to alleviate or manage the symptoms associated with excessive sweating, aiming to enhance the quality of life for individuals affected by this condition.

The primary types of hyperhidrosis treatments include topical treatments, surgical interventions, botulinum toxin A injections, iontophoresis, laser treatments, and other therapeutic approaches. Topical treatments involve the application of agents directly to the skin to address hyperhidrosis symptoms. Surgical treatments may be considered for certain cases, and botulinum toxin A injections are utilized to reduce excessive sweating. Iontophoresis and laser treatments are additional methods used to manage hyperhidrosis. These treatments can be administered through various routes, including oral and injectable, to address specific types of hyperhidrosis, such as axillary, palmar, plantar, and others. Hyperhidrosis treatments are available through different distribution channels, including hospitals, ambulatory surgical centers, retail pharmacies, and online platforms.

The hyperhidrosis treatment market research report is one of a series of new reports from The Business Research Company that provides hyperhidrosis treatment market statistics, including hyperhidrosis treatment industry global market size, regional shares, competitors with a hyperhidrosis treatment market share, detailed hyperhidrosis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the hyperhidrosis treatment industry. This hyperhidrosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hyperhidrosis treatment market size has grown strongly in recent years. It will grow from $1.48 billion in 2023 to $1.58 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The observed growth in the historic period for hyperhidrosis treatments can be attributed to several factors. These include increased awareness of cosmetic concerns related to excessive sweating, growing recognition of the psychosocial impact of hyperhidrosis, and regulatory support for addressing this medical condition. These factors collectively contributed to the heightened interest and utilization of treatments to manage hyperhidrosis symptoms during the historic period.

The hyperhidrosis treatment market size is expected to see strong growth in the next few years. It will grow to $1.99 billion in 2028 at a compound annual growth rate (CAGR) of 5.9%. The anticipated growth in the forecast period for hyperhidrosis treatments can be attributed to several factors. These include a shift towards patient-centric treatment approaches, increased global health awareness, advancements in topical therapies, innovations in surgical procedures, and the integration of hyperhidrosis treatments into comprehensive dermatology practices. Major trends expected in the forecast period include the adoption of personalized treatment approaches tailored to individual patient needs, technological innovations in medical devices used for hyperhidrosis treatment, ongoing research and development in oral medications targeting excessive sweating, the use of telemedicine for consultations and follow-ups, and increased collaborations and partnerships within the healthcare industry.

The anticipated rise in the occurrence of diabetes mellitus is poised to drive the expansion of the hyperhidrosis treatment market. Diabetes mellitus, characterized by abnormal insulin levels leading to high blood sugar levels, can affect the nervous system controlling sweat glands, resulting in excessive sweating or hyperhidrosis. This medical condition's impact on sweat regulation and body temperature maintenance can contribute to hyperhidrosis. For example, data from the International Diabetes Federation in December 2021 highlighted that 537 million adults between 20 to 79 years old were affected by diabetes in 2021, projecting an increase to 643 million by 2030 and an estimated 783 million by 2045. Thus, the escalating prevalence of diabetes mellitus is a significant driver for the hyperhidrosis treatment market.

The upward trend in healthcare expenditures is anticipated to fuel the growth of the hyperhidrosis treatment market. Healthcare expenditure encompasses spending on various medical services, including treatment, equipment, medication, and preventive care. The surge in healthcare expenditure has brought about heightened awareness regarding hyperhidrosis and its impact on individuals' daily routines and quality of life. This increased awareness has led to the development of new treatment methods, surgical interventions, and considerations for associated health conditions. For instance, a report by the UK's Office for National Statistics indicated a 9.4% nominal and 9.7% real-term increase in healthcare spending between 2020 and 2021. Specifically, preventive care expenditure surged to $45.72 billion in 2021, doubling from the previous year. Consequently, the escalating healthcare expenditures are propelling growth within the hyperhidrosis treatment market.

The exorbitant expense associated with hyperhidrosis treatment significantly hampers the expansion of the hyperhidrosis treatment market. The high cost of treatment poses a significant barrier to access for many patients, potentially restricting their ability to pursue available treatment options. This financial burden may limit market growth, as individuals facing hyperhidrosis may find themselves unable to afford the necessary treatments. For example, statistics from The American Society for Aesthetic Plastic Surgery indicated that the average cost of hyperhidrosis treatment in 2021 was $1,193, marking a 19% increase from the previous year. Thus, the elevated cost of hyperhidrosis treatment stands as a deterrent to the market's growth.

Key players within the hyperhidrosis treatment market are intensifying their efforts to introduce wipe formulations, strategically aiming to boost market revenues. Wipe formulations serve as a delivery method for applying medications or antiperspirants to the skin through pre-moistened wipes. These formulations effectively apply antiperspirant medication to alleviate excessive sweating. An illustration of this strategy can be seen with Maruho Co. Ltd.'s May 2022 launch of Rapifort Wipes 2.5% in Japan. These wipes feature glycopyrronium tosilate hydrate as an active component, reducing sweat production by impeding the activation of acetylcholine receptors in sweat glands. Application of this medication solution once daily to both underarms with a single-use non-woven cloth in each packet minimizes sweating. This convenient, hygienic single-use wipe addresses primary axillary hyperhidrosis, a condition characterized by unexplained excessive underarm sweating that can disrupt daily activities.

In June 2023, miraDry Inc., a United States-based company specializing in non-invasive hyperhidrosis treatment, entered into a partnership with the International Hyperhidrosis Society (IHhS). This collaboration is designed to facilitate cooperation between miraDry and the International Hyperhidrosis Society (IHhS) in order to enhance hyperhidrosis therapy. The partnership underscores miraDry's commitment to improving the lives of individuals experiencing excessive sweating. The International Hyperhidrosis Society (IHhS) is a non-profit organization based in the United States that serves millions of individuals affected by hyperhidrosis.

Major companies operating in the hyperhidrosis treatment market report are Pfizer Inc., AbbVie Inc., Sanofi S.A., AstraZeneca Plc, GSK plc, Teva Pharmaceutical Industries Ltd., Mylan N.V., Cynosure LLC, Ipsen SA, Galderma S.A., Merz Pharma GmbH & Co. KGaA, Daewoong Pharmaceutical Co. Ltd., Supernus Pharmaceuticals Inc, Kaken Pharmaceutical Co Ltd, Avanor Healthcare Ltd., HUGEL Inc., Evolus Inc., Revance Therapeutics Inc., Dermira Inc., Sesderma SL, Miramar Labs Inc., Dermavant Sciences Inc., Theravida Inc., SweatBlock, Brickell Biotech Inc., Fresh Tracks Therapeutics Inc., Advin Health Care Inc, Dermadry Laboratories Inc., Ulthera Inc., Dermata Therapeutics Inc.

North America was the largest region in the hyperhidrosis treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperhidrosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hyperhidrosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hyperhidrosis treatment market consists of revenues earned by entities by providing services such as microwave therapy, iontophoresis, sympathectomy, and sweat gland removal. The market value includes the value of related goods sold by the service provider or included within the service offering. The hyperhidrosis treatment market also includes sales of drysol, xerac AC, glycopyrrolate, benztropine and beta blockers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hyperhidrosis Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hyperhidrosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hyperhidrosis treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hyperhidrosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Treatment Type: Topical Treatments; Surgical Treatments; Botulin Toxin A; Iontophoresis; Laser Treatments; Other Treatments
  • 2) By Route of Administration: Oral; Injectable
  • 3) By Disease Type: Axillary hyperhidrosis; Palmar hyperhidrosis; Plantar hyperhidrosis; Other Diseases
  • 4) By Distribution Channel: Hospitals; Ambulatory Surgical Centers; Retail Pharmacies; Online
  • Companies Mentioned: Pfizer Inc.; AbbVie Inc.; Sanofi S.A.; AstraZeneca Plc; GSK plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hyperhidrosis Treatment Market Characteristics

3. Hyperhidrosis Treatment Market Trends And Strategies

4. Hyperhidrosis Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Hyperhidrosis Treatment Market Size and Growth

  • 5.1. Global Hyperhidrosis Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Hyperhidrosis Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Hyperhidrosis Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Hyperhidrosis Treatment Market Segmentation

  • 6.1. Global Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Topical Treatments
  • Surgical Treatments
  • Botulin Toxin A
  • Iontophoresis
  • Laser Treatments
  • Other Treatments
  • 6.2. Global Hyperhidrosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Injectable
  • 6.3. Global Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Axillary hyperhidrosis
  • Palmar hyperhidrosis
  • Plantar hyperhidrosis
  • Other Diseases
  • 6.4. Global Hyperhidrosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Retail Pharmacies
  • Online

7. Hyperhidrosis Treatment Market Regional And Country Analysis

  • 7.1. Global Hyperhidrosis Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Hyperhidrosis Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Hyperhidrosis Treatment Market

  • 8.1. Asia-Pacific Hyperhidrosis Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Hyperhidrosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Hyperhidrosis Treatment Market

  • 9.1. China Hyperhidrosis Treatment Market Overview
  • 9.2. China Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Hyperhidrosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Hyperhidrosis Treatment Market

  • 10.1. India Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Hyperhidrosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Hyperhidrosis Treatment Market

  • 11.1. Japan Hyperhidrosis Treatment Market Overview
  • 11.2. Japan Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Hyperhidrosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Hyperhidrosis Treatment Market

  • 12.1. Australia Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Hyperhidrosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Hyperhidrosis Treatment Market

  • 13.1. Indonesia Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Hyperhidrosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Hyperhidrosis Treatment Market

  • 14.1. South Korea Hyperhidrosis Treatment Market Overview
  • 14.2. South Korea Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Hyperhidrosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Hyperhidrosis Treatment Market

  • 15.1. Western Europe Hyperhidrosis Treatment Market Overview
  • 15.2. Western Europe Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Hyperhidrosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Hyperhidrosis Treatment Market

  • 16.1. UK Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Hyperhidrosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Hyperhidrosis Treatment Market

  • 17.1. Germany Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Hyperhidrosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Hyperhidrosis Treatment Market

  • 18.5. France Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Hyperhidrosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Hyperhidrosis Treatment Market

  • 19.9. Italy Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Hyperhidrosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Hyperhidrosis Treatment Market

  • 20.13. Spain Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Hyperhidrosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Hyperhidrosis Treatment Market

  • 21.1. Eastern Europe Hyperhidrosis Treatment Market Overview
  • 21.2. Eastern Europe Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Hyperhidrosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Hyperhidrosis Treatment Market

  • 22.1. Russia Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Hyperhidrosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Hyperhidrosis Treatment Market

  • 23.1. North America Hyperhidrosis Treatment Market Overview
  • 23.2. North America Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Hyperhidrosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Hyperhidrosis Treatment Market

  • 24.1. USA Hyperhidrosis Treatment Market Overview
  • 24.2. USA Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Hyperhidrosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Hyperhidrosis Treatment Market

  • 25.1. Canada Hyperhidrosis Treatment Market Overview
  • 25.2. Canada Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Hyperhidrosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Hyperhidrosis Treatment Market

  • 26.1. South America Hyperhidrosis Treatment Market Overview
  • 26.2. South America Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Hyperhidrosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Hyperhidrosis Treatment Market

  • 27.1. Brazil Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Hyperhidrosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Hyperhidrosis Treatment Market

  • 28.1. Middle East Hyperhidrosis Treatment Market Overview
  • 28.2. Middle East Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Hyperhidrosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Hyperhidrosis Treatment Market

  • 29.1. Africa Hyperhidrosis Treatment Market Overview
  • 29.2. Africa Hyperhidrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Hyperhidrosis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Hyperhidrosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Hyperhidrosis Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Hyperhidrosis Treatment Market Competitive Landscape
  • 30.2. Hyperhidrosis Treatment Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. AbbVie Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Sanofi S.A.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. AstraZeneca Plc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. GSK plc
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Hyperhidrosis Treatment Market Other Major And Innovative Companies

  • 31.1. Teva Pharmaceutical Industries Ltd.
  • 31.2. Mylan N.V.
  • 31.3. Cynosure LLC
  • 31.4. Ipsen SA
  • 31.5. Galderma S.A.
  • 31.6. Merz Pharma GmbH & Co. KGaA
  • 31.7. Daewoong Pharmaceutical Co. Ltd.
  • 31.8. Supernus Pharmaceuticals Inc
  • 31.9. Kaken Pharmaceutical Co Ltd
  • 31.10. Avanor Healthcare Ltd.
  • 31.11. HUGEL Inc.
  • 31.12. Evolus Inc.
  • 31.13. Revance Therapeutics Inc.
  • 31.14. Dermira Inc.
  • 31.15. Sesderma SL

32. Global Hyperhidrosis Treatment Market Competitive Benchmarking

33. Global Hyperhidrosis Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Hyperhidrosis Treatment Market

35. Hyperhidrosis Treatment Market Future Outlook and Potential Analysis

  • 35.1 Hyperhidrosis Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Hyperhidrosis Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Hyperhidrosis Treatment Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer